… coronary intervention with coronary artery bypass grafting in diabetic patients: 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial

…, A Baumbach, G Angelini, A de Belder… - Journal of the American …, 2010 - jacc.org
… to perform as complete a revascularization as possible. … Shown are the 1-year Kaplan-Meier
event-free survival curves for … the ARTS, the rate of revascularization was 22.3% at 1 year

Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease

VMG Legrand, PW Serruys, F Unger, BA van Hout… - Circulation, 2004 - Am Heart Assoc
event-free patient was 19 257 at 1 year but decreased to 10 492 at 3 years. It remained at
142 391 at 3 years when revascularizationtrial would have generated 1 additional event-free

… according to the completeness of revascularization in severe coronary artery disease: patient-level pooled analysis of the SYNTAX, PRECOMBAT, and BEST trials

JM Ahn, DW Park, CW Lee, M Chang… - JACC: Cardiovascular …, 2017 - jacc.org
… proportion of patients did not achieve complete revascularization (CR), particularly in …
effect of completeness of revascularization on event-free survival at one year in the ARTS trial

… in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial

G Weisz, P Généreux, A Iñiguez, A Zurakowski… - The Lancet, 2016 - thelancet.com
… of patients with versus without complete revascularisation after percutaneous coronary …
Ranolazine had no significant treatment effect on the need for revascularisation of each of …

… , angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results

W Hueb, PR Soares, BJ Gersh, LAM César… - Journal of the American …, 2004 - jacc.org
event-free survival. This superiority probably reflected a low perioperative complication rate,
symptomatic improvement, and the completeness of revascularization… In ARTS, there was no …

Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II) A randomized controlled clinical trial of 3 therapeutic strategies for multivessel …

W Hueb, N Lopes, BJ Gersh, PR Soares, EE Ribeiro… - Circulation, 2010 - Am Heart Assoc
… The effect of treatment on 10-year event-free survival was not changed by clinical … effect
of completeness of revascularization on event-free survival at one year in the ARTS trial

The adequacy of myocardial revascularization in patients with multivessel coronary artery disease

M Zimarino, N Curzen, V Cicchitti… - International journal of …, 2013 - Elsevier
… In the absence of any trial specifically designed to assess the … lower event-free survival
rate than those with complete … and even of ARTS and SYNTAX if revascularization had been …

Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes

EL Hannan, C Wu, G Walford, DR Holmes… - JACC: Cardiovascular …, 2009 - jacc.org
… , patients undergoing IR with stenting experienced significantly lower event-free survival (…
effect of completeness of revascularization on event-free survival at one year in the ARTS trial

… , predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year …

SJ Head, MJ Mack, DR Holmes Jr… - European journal of …, 2012 - academic.oup.com
… had an effect on the 3-year outcome of the SYNTAX trial. … The ARTS trial showed an 82.1
and 70.5% rate of complete … The rate of revascularization in the ARTS trial was probably higher …

One-year results of total arterial revascularization vs. conventional coronary surgery: CARRPO trial

S Damgaard, J Wetterslev, JT Lund… - European heart …, 2009 - academic.oup.com
… as mean patency index, and cardiac event-free survival, 1 and 5 years post-operatively. …
effect of completeness of revascularization on event-free survival at one year in the ARTS trial